![]() ![]() Its purpose is to support industry-academia collaborative research and development in the field of interdisciplinary medicine and engineering. It has been adopted under the name “Innovative Techno-hub for Integrated Medical Bio-imaging” as part of the “Creation of innovation centers for advanced interdisciplinary research areas program” supported by the MEXT Budget for the Promotion of Science and Technology. Kyoto University/Canon Joint Research Project (CK Project) is a joint project between Kyoto University and Canon for promoting close industry-academia collaboration to foster researchers and technicians who can effectively work in the integrated medical engineering fields and achieve advanced interdisciplinary innovations especially in the fields of diagnostic imaging technology for early detection and prevention of diseases in order to create a healthy society. This innovation center has been adopted to the program, “Formation of Innovation Center for Fusion of Advanced Technologies,” funded by the Japanese Science and Technology Agency (JST) under the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Kyoto University and Astellas will work jointly to achieve the break-through innovations in drug discovery system and innovative drugs of the next generation. In order to overcome these fundamental issues and discover new drugs to cure above severe diseases, the Faculty of Medicine, Kyoto University is starting to develop innovative “immunoregulative drugs and technologies” by co-researching with one of the biggest Japanese pharmaceutical companies Astellas Pharma Inc. ![]() Some of the critical processes for the drug development in the Japanese pharmaceutical industry still remain at a bottleneck, including discovery and identification of the novel target molecule for the drug discovery, rational drug design and synthesis, compound conversion technology, validation procedures for drug candidates in medical applications, technology to evaluate the advantages of biological drugs, and efficient translational research. It is evident that establishment of safe immunoregulation technologies is required for the development of organ transplantation and regenerative medicine, which are expected to be medical cures of the next generation. Further, several kinds of cancer still have high mortality rates and there are many patients suffering from intractable immunological diseases including autoimmune diseases. It has also been reported that more than 200 million people suffered from these diseases in the advanced nations. The morbidity of patients with the allergic diseases is now reaching almost one third of the total Japanese population. Through collaboration with the new start-up, it further promotes the establishment of future university spinouts and advances in further research. The plaza creates start-up business by selecting the researches, which holds promising business potential and investing the funding from Mitsubishi UFJ and Sumitomo Corporation into them. The Incubation Plaza is a committee (Incubation Program Committee) consisting of Kyoto University, Mitsubishi UFJ Capital and Sumitomo Corporation that aims to put advances in medical research into practical applications within society. Also providing support for contract negotiation and setting up of the start-up business, the Business Liaison Office of Kyoto University Faculty of Medicine functions as a one-stop shop for university-academia collaboration for the medical field. The office engages itself in many other technology transfer activities such as gathering information on ongoing research and projects, and assisting university researchers with patent applications, licensing and collaboration. It bridges the faculties in the medical field with industry through compiling university research and knowledge and emitting them to the outside. The objective of the Business Liaison Office of Kyoto University Faculty of Medicine is to promote further advances in the development of medical treatment and technology. The KUMBL Office consists of the Business Liaison Office of Kyoto University Faculty of Medicine and the Incubation Plaza. Excavating the seeds of innovation born within the medical field (centering around the Graduate School of Medicine) the office contributes to the development of improved healthcare by matching the university seeds with the market and industrial needs for collaborations. This aim can be said to be one of the three major objectives of national universities the first two being the education and the research itself. Opened in April 2002, the Office addresses the issue of how research achievements can be best returned for the benefit of society. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |